Risk factor associations for severe COVID-19, influenza and pneumonia in people with diabetes to inform future pandemic preparations: UK population-based cohort study

Rhian Hopkins,Katherine G Young,Nicholas J Thomas,James Godwin,Daniyal Raja,Bilal A Mateen,Robert J Challen,Sebastian J Vollmer,Beverley M Shields,Andrew P McGovern,John M Dennis
DOI: https://doi.org/10.1136/bmjopen-2023-078135
IF: 3.006
2024-02-01
BMJ Open
Abstract:Objective This study aimed to compare clinical and sociodemographic risk factors for severe COVID-19, influenza and pneumonia, in people with diabetes. Design Population-based cohort study. Setting UK primary care records (Clinical Practice Research Datalink) linked to mortality and hospital records. Participants Individuals with type 1 and type 2 diabetes (COVID-19 cohort: n=43 033 type 1 diabetes and n=584 854 type 2 diabetes, influenza and pneumonia cohort: n=42 488 type 1 diabetes and n=585 289 type 2 diabetes). Primary and secondary outcome measures COVID-19 hospitalisation from 1 February 2020 to 31 October 2020 (pre-COVID-19 vaccination roll-out), and influenza and pneumonia hospitalisation from 1 September 2016 to 31 May 2019 (pre-COVID-19 pandemic). Secondary outcomes were COVID-19 and pneumonia mortality. Associations between clinical and sociodemographic risk factors and each outcome were assessed using multivariable Cox proportional hazards models. In people with type 2 diabetes, we explored modifying effects of glycated haemoglobin (HbA1c) and body mass index (BMI) by age, sex and ethnicity. Results In type 2 diabetes, poor glycaemic control and severe obesity were consistently associated with increased risk of hospitalisation for COVID-19, influenza and pneumonia. The highest HbA1c and BMI-associated relative risks were observed in people aged under 70 years. Sociodemographic-associated risk differed markedly by respiratory infection, particularly for ethnicity. Compared with people of white ethnicity, black and south Asian groups had a greater risk of COVID-19 hospitalisation, but a lesser risk of pneumonia hospitalisation. Risk factor associations for type 1 diabetes and for type 2 diabetes mortality were broadly consistent with the primary analysis. Conclusions Clinical risk factors of high HbA1c and severe obesity are consistently associated with severe outcomes from COVID-19, influenza and pneumonia, especially in younger people. In contrast, associations with sociodemographic risk factors differed by type of respiratory infection. This emphasises that risk stratification should be specific to individual respiratory infections.
medicine, general & internal
What problem does this paper attempt to address?
The problem that this paper aims to solve is to compare the clinical and demographic risk factors of severe COVID - 19, influenza and pneumonia in diabetic patients, so as to guide future pandemic preparedness. Specifically, the research objectives include: 1. **Compare clinical and demographic risk factors**: The study aims to compare the clinical (such as HbA1c level, BMI, etc.) and demographic (such as age, gender, ethnicity, socioeconomic status, etc.) risk factors of severe COVID - 19, influenza and pneumonia in diabetic patients. 2. **Evaluate the heterogeneity of risk factors**: Especially in patients with type 2 diabetes, the study also evaluated the heterogeneity of the risk between HbA1c and BMI and different age, gender and ethnic subgroups. 3. **Provide the basis for risk stratification**: By comparing the associations of these risk factors in different respiratory infections, the study provides a scientific basis for future risk stratification and targeted interventions. ### Research design and methods - **Data sources**: The study used data from the Clinical Practice Research Datalink (CPRD) Aurum in the UK, which is a large, population - based medical record database. - **Study population**: It includes patients with type 1 and type 2 diabetes, who were registered on February 1, 2020 and September 1, 2016 respectively. - **Primary outcomes**: COVID - 19 hospitalization from February 1, 2020 to October 31, 2020, and influenza and pneumonia hospitalization from September 1, 2016 to May 31, 2019. - **Statistical analysis**: Multivariate Cox proportional - hazards models were used to identify risk factors for hospitalization due to various infections and to evaluate hazard ratios (HRs). ### Main findings - **High HbA1c and severe obesity**: High HbA1c (> 86 mmol/mol) and severe obesity (BMI > 30 kg/m²) were significantly associated with an increased risk of hospitalization for all three respiratory infections. - **Age and gender differences**: The associations between HbA1c and BMI and the risk of hospitalization were more pronounced in people under 70 years old. The association between BMI and the risk of hospitalization was stronger in women and people under 70 years old. - **Ethnicity and socioeconomic status**: Non - white ethnicity, male gender and higher socioeconomic deprivation were associated with a higher risk of COVID - 19 hospitalization, but with a lower risk of pneumonia hospitalization. ### Conclusion The research results emphasize that high HbA1c and severe obesity are consistent risk factors for hospitalization and death from all three respiratory infections in diabetic patients, especially in younger people. However, the associations of demographic risk factors vary according to the type of respiratory infection, indicating that risk stratification should be carried out for specific respiratory infections.